TRANSFORMING GROWTH FACTORS IN COLONIC NEOPLASIA

结肠肿瘤中的转化生长因子

基本信息

  • 批准号:
    3189666
  • 负责人:
  • 金额:
    $ 15.57万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1988
  • 资助国家:
    美国
  • 起止时间:
    1988-05-01 至 1991-04-30
  • 项目状态:
    已结题

项目摘要

The overall objective of these studies is to evaluate the role of stimulatory and inhibitory autocrine growth factor activities in growth regulation of normal and neoplastic colonic epithelia. In addition, the effects of alterations in these pathways on tumor progression will be addressed. The use of established polyp cell lines and colon carcinoma cell lines which phenotypically range from well differentiated to poorly differentiated will allow investigation of growth factor requirements and production, growth factor receptor expression, and potential post receptor events necessary for signal transduction consequential to ligand binding. Furthermore, answers obtained from these approaches in cultured cells will be applied to primary specimens of normal colon tissue, polyp and carcinoma samples in an effort to correlate in vitro and in vivo findings. Specifically, TGF alpha and TGF beta activities will be characterized in all cell types with regard to production and response at the transcriptional and translational levels. Tools such as Northern and Southern blot analyses, radioreceptor assay, radioimmunoassay, and immunoprecipitation will be employed to examine the role of these growth factors in growth control, as well as dissect potential mechanisms by which neoplastic cells have managed to alter these mechanisms. Potential amplification of production of stimulatory molecules (TGF alpha) and/or diminution of response to inhibitory signals (TGF beta) could be hallmark events in the establishment and progression of tumor formation. The colonic epithelium is a useful model system to study such progression because normal, preneoplastic (polyp) and several stages of neoplastic tissue are available. If a role for these putative autocrine regulators is established, possible ways to block positive signals or increase responses to inhibitory signals will be examined. In these studies, specific antibodies to the growth factors or their receptors will be used. The scope of this proposal encompasses not only the identification of growth factors necessary for maintenance of normal colonic epithelia, but also the sequential alterations in normal control pathways that have contributed to colonic dysplasia and ultimately neoplasia. These studies are designed to increase our understanding of normal and neoplastic proliferation of colonic epithelia, and thus provide insight into possible ways to redirect neoplastic cells onto a normal course of growth control.
这些研究的总体目标是评估 刺激和抑制自分泌生长因子活性的研究 正常和肿瘤结肠上皮细胞的生长调控。在……里面 此外,这些通路的改变对肿瘤的影响 进展将得到解决。已建立的息肉细胞的使用 表型范围为 从高分化到低分化将允许 生长因子需求和产量调查, 生长因子受体的表达和潜在的受体后 与配体相关的信号转导所必需的事件 有约束力的。此外,从这些方法中获得的答案在 将培养的细胞应用于正常皮肤的原代标本 结肠组织、息肉和癌症样本 相关的体外和体内的研究结果。具体来说,转化生长因子α 转化生长因子β的活性将在所有类型的细胞中进行表征 关于转录和反应中的生产和反应 翻译级别。北方和南方印迹等工具 分析、放射受体分析、放射免疫分析和 免疫沉淀法将被用来检测 这些生长因子在生长控制中,以及解剖 肿瘤细胞成功地通过其潜在的机制 改变这些机制。生产潜力放大 刺激分子(转化生长因子α)和/或反应减弱 对抑制信号(转化生长因子β)可能是标志性事件 肿瘤形成的发生和发展。结肠 上皮细胞是研究这种进展的有用的模型系统。 因为正常、癌前病变(息肉)和几个阶段的 有肿瘤组织可用。如果这些推定的角色 自分泌监管机构成立,可能有方法阻止积极 信号或增加对抑制信号的反应将是 检查过了。在这些研究中,针对生长的特定抗体 将使用因子或其受体。这项提案的范围 不仅包括确定增长因素 对维持正常的结肠上皮是必要的,但也 正常控制通路中的顺序变化具有 导致结肠发育不良,并最终形成肿瘤。这些 研究的目的是增加我们对正常和 结肠上皮的肿瘤性增殖,从而提供 洞察可能的方法将肿瘤细胞重定向到 正常的生长控制过程。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Robert J. Coffey其他文献

Studies on uterine collagenase in tissue culture. II. Effect of steroid hormones on enzyme production.
组织培养子宫胶原酶的研究。
  • DOI:
  • 发表时间:
    1971
  • 期刊:
  • 影响因子:
    0
  • 作者:
    John J. Jeffrey;Robert J. Coffey;A. Z. Eisen
  • 通讯作者:
    A. Z. Eisen
Stereotactic drainage of Aspergillus brain abscess with long-term survival: case report and review.
曲霉菌脑脓肿的立体定向引流与长期生存:病例报告和回顾。
  • DOI:
  • 发表时间:
    1989
  • 期刊:
  • 影响因子:
    4.8
  • 作者:
    Michael L. Goodman;Robert J. Coffey
  • 通讯作者:
    Robert J. Coffey
Sa1613 - Expression of Lrig1, a Negative Regulator of Egfr, is Dynamically Altered in Different Stages of Gastric Carcinogenesis
  • DOI:
    10.1016/s0016-5085(18)31437-9
  • 发表时间:
    2018-05-01
  • 期刊:
  • 影响因子:
  • 作者:
    Hyunji Kim;Sungsook Yu;Yejin Cho;Robert J. Coffey;James R. Goldenring;Ki Taek Nam;Mijeong Yang;Keunwook Lee;Sang-Ho Jeong;Kyung-Min Lim
  • 通讯作者:
    Kyung-Min Lim
Sa1629 - Testosterone-Dependent Differential Expression of Egfr in Male and Female Mice and Its Implications for Carcinogenesis and Treatment Response
  • DOI:
    10.1016/s0016-5085(18)31453-7
  • 发表时间:
    2018-05-01
  • 期刊:
  • 影响因子:
  • 作者:
    Won Jae Huh;Kathleen Rhoades;Robert J. Coffey
  • 通讯作者:
    Robert J. Coffey
Tu1204 BETTER UNDERSTANDING OF MENETRIER'S DISEASE ANDJUVENILE POLYPOSIS SYNDROME BY RNA SEQUENCING
  • DOI:
    10.1016/s0016-5085(20)33215-7
  • 发表时间:
    2020-05-01
  • 期刊:
  • 影响因子:
  • 作者:
    Sargoel Rezanejad;Marisol A. Ramirez;Qi Liu;Robert J. Coffey;Won Jae Huh
  • 通讯作者:
    Won Jae Huh

Robert J. Coffey的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Robert J. Coffey', 18)}}的其他基金

Integrative Single-Cell Atlas of Host and Microenvironment in Colorectal Neoplastic Transformation
结直肠肿瘤转化中宿主和微环境的综合单细胞图谱
  • 批准号:
    10820067
  • 财政年份:
    2023
  • 资助金额:
    $ 15.57万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10900839
  • 财政年份:
    2023
  • 资助金额:
    $ 15.57万
  • 项目类别:
Shaping the Microenvironment by DPEP1 Facilitates Adenoma Progression
通过 DPEP1 塑造微环境促进腺瘤进展
  • 批准号:
    10518847
  • 财政年份:
    2022
  • 资助金额:
    $ 15.57万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10518846
  • 财政年份:
    2022
  • 资助金额:
    $ 15.57万
  • 项目类别:
Shaping the Microenvironment by DPEP1 Facilitates Adenoma Progression
通过 DPEP1 塑造微环境促进腺瘤进展
  • 批准号:
    10697369
  • 财政年份:
    2022
  • 资助金额:
    $ 15.57万
  • 项目类别:
Role of WNT-EGFR crosstalk by EVs and exomeres in normal colon and colon cancer
EV 和外泌体 WNT-EGFR 串扰在正常结肠和结肠癌中的作用
  • 批准号:
    10544807
  • 财政年份:
    2020
  • 资助金额:
    $ 15.57万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10218105
  • 财政年份:
    2019
  • 资助金额:
    $ 15.57万
  • 项目类别:
Project 1: Interrogating Distinct Tumor-Initiating Cells in CRC
项目 1:研究 CRC 中不同的肿瘤起始细胞
  • 批准号:
    10700848
  • 财政年份:
    2019
  • 资助金额:
    $ 15.57万
  • 项目类别:
Distribution of Molecular Features for Colorectal Cancers in Northern Tanzania
坦桑尼亚北部结直肠癌的分子特征分布
  • 批准号:
    10845027
  • 财政年份:
    2019
  • 资助金额:
    $ 15.57万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10912861
  • 财政年份:
    2019
  • 资助金额:
    $ 15.57万
  • 项目类别:

相似海外基金

Preoperative molecular diagnosis with novel follicular thyroid carcinoma-specific markers using cytology and blood samples
使用细胞学和血液样本进行新型滤泡性甲状腺癌特异性标记物的术前分子诊断
  • 批准号:
    23K08060
  • 财政年份:
    2023
  • 资助金额:
    $ 15.57万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Impact of sarcopenia and creation of novel therapeutic targets by immunotherapeutic resistance mechanisms in hepatocellular carcinoma
肌少症的影响以及通过免疫治疗耐药机制创建新的治疗靶点对肝细胞癌的影响
  • 批准号:
    23K08106
  • 财政年份:
    2023
  • 资助金额:
    $ 15.57万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Combination therapy for renal cell carcinoma using oncolytic virus G47d
使用溶瘤病毒 G47d 联合治疗肾细胞癌
  • 批准号:
    23K08752
  • 财政年份:
    2023
  • 资助金额:
    $ 15.57万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of transcatheter arterial embolization for controlling hypoxia in hepatocellular carcinoma
经导管动脉栓塞控制肝细胞癌缺氧的研究进展
  • 批准号:
    23K07075
  • 财政年份:
    2023
  • 资助金额:
    $ 15.57万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Dissecting the roles of iron and hemojuvelin in hepatocellular carcinoma
剖析铁和血幼素在肝细胞癌中的作用
  • 批准号:
    478251
  • 财政年份:
    2023
  • 资助金额:
    $ 15.57万
  • 项目类别:
    Operating Grants
Analysis of the antioxidant function of xCT in lymphatic endothelial cells and its significance in oral squamous cell carcinoma.
淋巴管内皮细胞xCT抗氧化功能分析及其在口腔鳞癌中的意义
  • 批准号:
    23K16139
  • 财政年份:
    2023
  • 资助金额:
    $ 15.57万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Search for therapeutic target molecules based on temporal hierarchical analysis of Oral squamous cell carcinoma and functional RNA molecules
基于口腔鳞状细胞癌和功能RNA分子的时间层次分析寻找治疗靶分子
  • 批准号:
    23K16142
  • 财政年份:
    2023
  • 资助金额:
    $ 15.57万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Investigating a new vulnerability in oral squamous cell carcinoma
研究口腔鳞状细胞癌的新脆弱性
  • 批准号:
    10714352
  • 财政年份:
    2023
  • 资助金额:
    $ 15.57万
  • 项目类别:
"Role of Amplified Protein Kinases in Head and Neck Squamous Cell Carcinoma Progression and Therapy Resistance."
“扩增的蛋白激酶在头颈鳞状细胞癌进展和治疗耐药中的作用。”
  • 批准号:
    10725901
  • 财政年份:
    2023
  • 资助金额:
    $ 15.57万
  • 项目类别:
Determinants of immunotherapy response in NASH-Hepatocellular carcinoma
NASH-肝细胞癌免疫治疗反应的决定因素
  • 批准号:
    10735947
  • 财政年份:
    2023
  • 资助金额:
    $ 15.57万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了